Related Experiment Video
Updated: Jan 9, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Focal Atrial Tachycardia During Central Gemcitabine Administration
Jaspal Singh Gill1, Akansha Sethi1, Marco Pinto1
1Cardiovascular Department, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Gemcitabine can cause heart rhythm problems, particularly when administered through central venous catheters placed improperly. This case highlights the importance of considering the chemotherapy agent as a potential cause of arrhythmias.
Area of Science:
- Cardiology
- Oncology
- Pharmacology
Background:
- Gemcitabine is generally not considered cardiotoxic or arrhythmogenic.
- Chemotherapeutic agents can present unexpected adverse effects.
Related Concept Videos
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure Drugs: Inotropic Agents

